Cargando…
The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran
ABSTRACT: This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in the patients at a referral hospital in Fars province as well as the economic burden of COVID-19 in Iran in 2020. METHODS: This study is a p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877330/ https://www.ncbi.nlm.nih.gov/pubmed/33573650 http://dx.doi.org/10.1186/s12913-021-06126-8 |
_version_ | 1783650144321798144 |
---|---|
author | Ghaffari Darab, Mohsen Keshavarz, Khosro Sadeghi, Elnaz Shahmohamadi, Javad Kavosi, Zahra |
author_facet | Ghaffari Darab, Mohsen Keshavarz, Khosro Sadeghi, Elnaz Shahmohamadi, Javad Kavosi, Zahra |
author_sort | Ghaffari Darab, Mohsen |
collection | PubMed |
description | ABSTRACT: This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in the patients at a referral hospital in Fars province as well as the economic burden of COVID-19 in Iran in 2020. METHODS: This study is a partial economic evaluation and a cross-sectional cost-description study conducted based on the data of the COVID-19 patients referred to a referral university hospital in Fars province between March and July 2020. The data were collected by examining the patients’ records and accounting information systems. The subjects included all the inpatients with COVID-19 (477 individuals) who admitted to the medical centre during the 4 months. Bottom-up costing (also called micro-costing approach), incidence-based and income-based human capital approaches were used as the main methodological features of this study. RESULTS: The direct medical costs were estimated to be 28,240,025,968 Rials ($ 1,791,172) in total with mean cost of 59,203,409 Rials ($ 3755) per person (SD = 4684 $/ 73,855,161 Rials) in which significant part (41%) was that of intensive and general care beds (11,596,217,487 Rials equal to $ 735,510 (M = 24,310,728 Rials or $ 1542, SD = 34,184,949 Rials or $ 2168(. The second to which were the costs of medicines and medical consumables (28%). The mean indirect costs, including income loss due to premature death, economic production loss due to hospitalization and job absenteeism during recovery course were estimated to be 129,870,974 Rials ($ 11,634) per person. Furthermore, the economic burden of the disease in the country for inpatient cases with the definitive diagnosis was 22,688,925,933,095 Rials equal to $ 1,439,083,784. CONCLUSION: The results of this study showed that the severe status of the disease would bring about the extremely high cost of illness in this case. It is estimated that the high prevalence rate of COVID-19 has been imposing a heavy economic burden on the country and health system directly that may result in rationing or painful cost-control approaches. |
format | Online Article Text |
id | pubmed-7877330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78773302021-02-16 The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran Ghaffari Darab, Mohsen Keshavarz, Khosro Sadeghi, Elnaz Shahmohamadi, Javad Kavosi, Zahra BMC Health Serv Res Research Article ABSTRACT: This study aimed to estimate both direct medical and indirect costs of treating the Coronavirus disease 2019 (COVID-19) from a societal perspective in the patients at a referral hospital in Fars province as well as the economic burden of COVID-19 in Iran in 2020. METHODS: This study is a partial economic evaluation and a cross-sectional cost-description study conducted based on the data of the COVID-19 patients referred to a referral university hospital in Fars province between March and July 2020. The data were collected by examining the patients’ records and accounting information systems. The subjects included all the inpatients with COVID-19 (477 individuals) who admitted to the medical centre during the 4 months. Bottom-up costing (also called micro-costing approach), incidence-based and income-based human capital approaches were used as the main methodological features of this study. RESULTS: The direct medical costs were estimated to be 28,240,025,968 Rials ($ 1,791,172) in total with mean cost of 59,203,409 Rials ($ 3755) per person (SD = 4684 $/ 73,855,161 Rials) in which significant part (41%) was that of intensive and general care beds (11,596,217,487 Rials equal to $ 735,510 (M = 24,310,728 Rials or $ 1542, SD = 34,184,949 Rials or $ 2168(. The second to which were the costs of medicines and medical consumables (28%). The mean indirect costs, including income loss due to premature death, economic production loss due to hospitalization and job absenteeism during recovery course were estimated to be 129,870,974 Rials ($ 11,634) per person. Furthermore, the economic burden of the disease in the country for inpatient cases with the definitive diagnosis was 22,688,925,933,095 Rials equal to $ 1,439,083,784. CONCLUSION: The results of this study showed that the severe status of the disease would bring about the extremely high cost of illness in this case. It is estimated that the high prevalence rate of COVID-19 has been imposing a heavy economic burden on the country and health system directly that may result in rationing or painful cost-control approaches. BioMed Central 2021-02-11 /pmc/articles/PMC7877330/ /pubmed/33573650 http://dx.doi.org/10.1186/s12913-021-06126-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Ghaffari Darab, Mohsen Keshavarz, Khosro Sadeghi, Elnaz Shahmohamadi, Javad Kavosi, Zahra The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title | The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title_full | The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title_fullStr | The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title_full_unstemmed | The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title_short | The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran |
title_sort | economic burden of coronavirus disease 2019 (covid-19): evidence from iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877330/ https://www.ncbi.nlm.nih.gov/pubmed/33573650 http://dx.doi.org/10.1186/s12913-021-06126-8 |
work_keys_str_mv | AT ghaffaridarabmohsen theeconomicburdenofcoronavirusdisease2019covid19evidencefromiran AT keshavarzkhosro theeconomicburdenofcoronavirusdisease2019covid19evidencefromiran AT sadeghielnaz theeconomicburdenofcoronavirusdisease2019covid19evidencefromiran AT shahmohamadijavad theeconomicburdenofcoronavirusdisease2019covid19evidencefromiran AT kavosizahra theeconomicburdenofcoronavirusdisease2019covid19evidencefromiran AT ghaffaridarabmohsen economicburdenofcoronavirusdisease2019covid19evidencefromiran AT keshavarzkhosro economicburdenofcoronavirusdisease2019covid19evidencefromiran AT sadeghielnaz economicburdenofcoronavirusdisease2019covid19evidencefromiran AT shahmohamadijavad economicburdenofcoronavirusdisease2019covid19evidencefromiran AT kavosizahra economicburdenofcoronavirusdisease2019covid19evidencefromiran |